Zeria obtains Japanese regulatory clearance for HemCon products

HemCon Medical Technologies, Inc. is pleased to announce that its partner in Japan, Zeria Pharmaceutical Co., Ltd., has obtained regulatory clearance from the Ministry of Health Labor and Welfare for the HemCon^® Bandage, GuardaCare™ and ChitoGauze™ product lines and will begin sales through Zeria's subsidiary, Zeria Shoji Co., Ltd.

“We are very pleased with the progress Zeria has made in getting our products approved and launched for sale in Japan”

In accordance with the agreement signed between HemCon and Zeria in April of last year, other products in the HemCon family will be added to Zeria's offerings in the coming months, with various distribution and sales mechanisms to be employed.

"We are very pleased with the progress Zeria has made in getting our products approved and launched for sale in Japan," said Nick Hart, HemCon's newly appointed President. "We look forward to additional product introductions and continuing to expand on this key partnership in Japan," added Hart.